ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 539

Thyroid Function in Early Versus Established Rheumatoid Arthritis

Suad Hannawi1, Issa Al Salmi2 and Haifa Hannawi3, 1Rheumatology Department. Ministry of Health and Prevention, Asst.Prof, Dubai, United Arab Emirates, 2Prof, Muscat, Oman, 3Research Department. Ministry of Health and Prevention, Asst.Prof, Dubai, United Arab Emirates

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Co-morbidities, rheumatoid arthritis (RA) and thyroid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Thyroid dysfunction is common in rheumatoid arthritis (RA). Subclinical hypothyroidism is the first most common, followed by clinical hypothyroidism. Thyroid dysfunction in RA had been found to increase the risk of cardiovascular disease. Subclinical hypothyroidism is defined as increased serum thyroid stimulating hormone (TSH) concentration with normal serum free thyroxine (T4) level. The aim of this study was to compare the thyroid function in early RA patients (of less than one-year duration of RA symptoms) versus established RA patients (of more than or equal to one-year duration of RA symptoms).

Methods:

We recruited 35 early RA patients (ERA) and 52 established RA patients attending specialized rheumatology clinic. All the patients had no clinical evidence of thyroid dysfunction. Patients with diabetes, pregnancy, renal and liver impairment were excluded. Fasting Free thyroxine (FT4), Free triiodothyronine (FT3), and thyroid stimulating hormone (TSH) were assessed in all the participants. t-test was used to compare the RA disease characteristics and the thyroid function between early and established RA. P value of <0.05 was considered significant.

Results:

Rheumatoid arthritis patients had been recruited through a specialized rheumatology clinic, 35 were with new onset rheumatoid arthritis (early RA; ERA of less than a year of RA symptoms onset) and 52 were with established RA (of more than a year of RA symptoms onset). The mean RA duration was 7.4 ± 2.0 months for ERA and 96 ± 92 months for the established RA group. There were no significant differences in age (45.76 ± 2.45 years for ERA vs. established RA respectively, p=0.49), or in gender distribution (31 F and 4 M in ERA vs. 46 F and 6 M in established RA, p=0.9) between the two groups.

ERA compared to the established RA group had more active RA as manifested by more swollen 28- joints (5.7 vs 1.7, respectively, p=0.001), more tender 28-joints (17 vs 11, respectively, p=0.01), higher DAS-28-ESR score (5.8 vs 4.5, respectively, p.0001), higher DAS 28-CRP score (5.1 vs. 3.9, respectively, p=0.001), and longer morning stiffness duration (in minutes) (p=0.04). As well, ERA had lower HDL level (1.4 vs 1.2, respectively, p=0.04). On the other hand, established-RA patients had RA disease onset at an earlier age than the EAR group (36.5 vs 44 years, respectively, p=0.02)

While the mean TSH, T3 and T4 were within normal range in both groups, there were significant differences in the mean values between ERA and established RA. TSH was 2.12±1.52 in ERA vs. 5.8±8.3 in established RA (NR:0.27-4.2 mlU/L), p=0.04. Mean FT3 was 4.54± 0.53 in ERA vs. 3.61± 1.13 in the established RA (NR: 4-6.8 pmol/L), p=0.04. Average FT4 was 17.7 ± 4.77 in ERA vs. 15.3 ± 2.51 in the established RA (NR: 12-22 pmol/L), p=0.01.

Conclusion:

RA patients with more than a year of RA symptoms are at a higher risk of silent autoimmune thyroid disease than their age sex matched RA patients with new onset RA; of less than a year of RA symptoms onset. Regular assessment of thyroid function might be an important part in the routine biochemical and immunological profile screening of RA.


Disclosure: S. Hannawi, None; I. Al Salmi, None; H. Hannawi, None.

To cite this abstract in AMA style:

Hannawi S, Al Salmi I, Hannawi H. Thyroid Function in Early Versus Established Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/thyroid-function-in-early-versus-established-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/thyroid-function-in-early-versus-established-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology